STOCK TITAN

Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Prenetics (NASDAQ: PRE) announced its participation in the upcoming Sidoti Virtual Micro Cap Conference scheduled for November 13-14, 2024. CEO Danny Yeung and CFO Stephen Lo will deliver a virtual presentation on November 13th at 8:30 a.m. ET. The presentation will be accessible through the company's investor relations website. Management will also be available for one-on-one meetings with investors on November 13th.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

% News Effect

On the day this news was published, PRE declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

CHARLOTTE, N.C., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, announced today that management will participate in the Sidoti Virtual Micro Cap Conference being held on November 13-14, 2024.

Prenetics’ Chief Executive Officer Danny Yeung and Chief Financial Officer Stephen Lo will present virtually on Wednesday, November 13th at 8:30 a.m. ET. A link to the webcast can be accessed through the investor section of the Company’s website at https://ir.prenetics.com/.

Additionally, management will be available for one-on-one investor meetings on Wednesday, November 13th. To schedule a one-on-one meeting with Prenetics’ management, please contact your Sidoti representative or reach out to investor relations at PRE@mzgroup.us.

About Prenetics
Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand and Europa, one of the largest sports distribution companies in the USA. Our clinical division is led by Insighta, our $200 million venture focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer comprehensive DNA tests. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’. To learn more about Prenetics, please visit www.prenetics.com.

Investor Relations Contact:
investors@prenetics.com
PRE@mzgroup.us

Angela Cheung
Investor Relations / Corporate Finance
Prenetics Global Limited
angela.hm.cheung@prenetics.com


FAQ

When is Prenetics (PRE) presenting at the Sidoti Virtual Micro Cap Conference 2024?

Prenetics (PRE) will present at the Sidoti Virtual Micro Cap Conference on Wednesday, November 13th, 2024, at 8:30 a.m. ET.

How can investors access Prenetics' (PRE) presentation at the Sidoti Conference?

Investors can access Prenetics' presentation through the investor section of the company's website at https://ir.prenetics.com/.

How can investors schedule one-on-one meetings with Prenetics (PRE) management at the Sidoti Conference?

Investors can schedule one-on-one meetings with Prenetics management by contacting their Sidoti representative or reaching out to investor relations at PRE@mzgroup.us.
Prenetics Ltd

NASDAQ:PRE

PRE Rankings

PRE Latest News

PRE Latest SEC Filings

PRE Stock Data

268.92M
14.55M
19.88%
12.67%
0.48%
Diagnostics & Research
Accident & Health Insurance
Link
Hong Kong
PEMBROKE